Ken Griffin’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$310M Sell
2,554,703
-8,401
-0.3% -$990K 0.03% 394
2026
Q2
$259M Buy
2,563,104
+2,051,217
+401% +$212M 0.03% 435
2026
Q1
$49.5M Buy
511,887
+394,416
+336% +$40.4M 0.01% 1369
2025
Q4
$12.5M Sell
117,471
-194,183
-62% -$22.5M ﹤0.01% 2960
2025
Q3
$39.6M Sell
311,654
-668,742
-68% -$79.6M 0.01% 1615
2025
Q2
$120M Buy
980,396
+40,341
+4% +$4.61M 0.02% 650
2025
Q1
$95.2M Buy
940,055
+506,139
+117% +$49.4M 0.02% 728
2024
Q4
$40.1M Sell
433,916
-341,339
-44% -$33.5M 0.01% 1474
2024
Q3
$74.9M Sell
775,255
-761,162
-50% -$68.4M 0.01% 912
2024
Q2
$132M Buy
1,536,417
+672,404
+78% +$56.4M 0.03% 534
2024
Q1
$71.4M Buy
864,013
+286,230
+50% +$21M 0.01% 951
2023
Q4
$38.5M Sell
577,783
-1,292,946
-69% -$83.7M 0.01% 1388
2023
Q3
$126M Buy
1,870,729
+862,748
+86% +$59.3M 0.03% 511
2023
Q2
$68.3M Sell
1,007,981
-114,111
-10% -$7.15M 0.01% 825
2023
Q1
$60.7M Sell
1,122,092
-361,328
-24% -$21M 0.01% 927
2022
Q4
$88.7M Buy
1,483,420
+468,326
+46% +$25.5M 0.02% 712
2022
Q3
$45.9M Buy
1,015,094
+1,010,217
+20,714% +$50.5M 0.01% 1140
2022
Q2
$274K Sell
4,877
-68,820
-93% -$4.44M ﹤0.01% 9994
2022
Q1
$5.24M Sell
73,697
-82,029
-53% -$5.38M ﹤0.01% 4081
2021
Q4
$10.2M Sell
155,726
-89,080
-36% -$5.78M ﹤0.01% 3050
2021
Q3
$18.4M Sell
244,806
-940,668
-79% -$74.4M ﹤0.01% 2127
2021
Q2
$92.5M Buy
1,185,474
+82,103
+7% +$6.88M 0.02% 717
2021
Q1
$90.4M Buy
1,103,371
+691,878
+168% +$56.7M 0.02% 636
2020
Q4
$34M Sell
411,493
-442,440
-52% -$32.7M 0.01% 1278
2020
Q3
$55.5M Buy
853,933
+660,151
+341% +$42.6M 0.02% 790
2020
Q2
$12M Sell
193,782
-999,959
-84% -$67.8M ﹤0.01% 2019
2020
Q1
$76.4M Buy
1,193,741
+565,697
+90% +$41M 0.03% 448
2019
Q4
$43.5M Sell
628,044
-169,331
-21% -$11.6M 0.02% 859
2019
Q3
$50.5M Buy
797,375
+62,655
+9% +$3.96M 0.02% 757
2019
Q2
$46.6M Buy
734,720
+282,806
+63% +$17.3M 0.02% 767
2019
Q1
$26.4M Sell
451,914
-31,501
-7% -$2.01M 0.01% 1108
2018
Q4
$29.8M Buy
483,415
+403,317
+504% +$28.8M 0.02% 928
2018
Q3
$6.24M Buy
80,098
+73,486
+1,111% +$5.62M ﹤0.01% 2703
2018
Q2
$448K Sell
6,612
-704
-10% -$44.2K ﹤0.01% 6551
2018
Q1
$418K Sell
7,316
-166,922
-96% -$8.99M ﹤0.01% 6206
2017
Q4
$8.61M Sell
174,238
-72,180
-29% -$3.45M 0.01% 1880
2017
Q3
$11.4M Buy
246,418
+86,370
+54% +$3.87M 0.01% 1489
2017
Q2
$7.75M Buy
160,048
+70,174
+78% +$3.23M 0.01% 1677
2017
Q1
$3.85M Buy
89,874
+53,138
+145% +$2.19M ﹤0.01% 2310
2016
Q4
$1.52M Buy
36,736
+21,888
+147% +$893K ﹤0.01% 3294
2016
Q3
$602K Buy
14,848
+6,053
+69% +$247K ﹤0.01% 4568
2016
Q2
$341K Buy
8,795
+666
+8% +$26.2K ﹤0.01% 5185
2016
Q1
$306K Sell
8,129
-19,003
-70% -$660K ﹤0.01% 5235
2015
Q4
$945K Buy
27,132
+26,093
+2,511% +$933K ﹤0.01% 3769
2015
Q3
$40K Sell
1,039
-55,624
-98% -$2.43M ﹤0.01% 7923
2015
Q2
$2.61M Buy
56,663
+52,540
+1,274% +$2.35M ﹤0.01% 2818
2015
Q1
$183K Sell
4,123
-73,394
-95% -$3.16M ﹤0.01% 6434
2014
Q4
$2.98M Sell
77,517
-357,598
-82% -$14M ﹤0.01% 2547
2014
Q3
$16.1M Buy
+435,115
New +$16.7M 0.02% 1053
2014
Q2
– Sell
-47,460
Closed -$1.7M – 8204
2014
Q1
$1.7M Sell
47,460
-882
-2% -$28.9K ﹤0.01% 2902
2013
Q4
$1.61M Buy
+48,342
New +$1.69M ﹤0.01% 2757
2013
Q3
– Sell
-2,956
Closed -$85K – 6762
2013
Q2
$85K Hold
2,956
– – ﹤0.01% 5333

Other funds holding EHC

Ken Griffin's EHC Position: Q3 2026 in Review

Ken Griffin reduced its Encompass Health (EHC) stake by 0.33% in Q3 2026, selling an estimated $990K and leaving 2,554,703 shares worth $310M. The position accounts for 0.03% of the portfolio, ranked #394.

Ken Griffin first reported a position in EHC in Q2 2013 and has held it in 52 quarters since. 630 funds tracked by Wall St. Rank hold EHC as of Q3 2026.

  • Ken Griffin held 2,554,703 shares of Encompass Health worth $310M as of Q3 2026.
  • Ken Griffin sold 8,401 Encompass Health shares in Q3 2026, an estimated $990K.
  • Encompass Health made up 0.03% of Ken Griffin's portfolio in Q3 2026, its #394 holding.
  • Ken Griffin first reported a position in Encompass Health in Q2 2013 and has held it in 52 quarters since.
  • 630 funds tracked by Wall St. Rank held Encompass Health as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.